Colistimethate Sodium - An Overview
Success of the second comparative study were reported by Flinn et al. This is the period III randomized Intergroup trial evaluating FC routine versus FAMP alone in 278 people obtaining their 1st chemotherapy regimen for B-CLL. Dosages of FC schedule were being the same as the very first study.Ailments OF USE: The information In this particular data